Stay updated on ADVOCATE: Avacopan Clinical Trial
Sign up to get notified when there's something new on the ADVOCATE: Avacopan Clinical Trial page.

Latest updates to the ADVOCATE: Avacopan Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and included the Revision: v3.3.2 tag; replaced the previous PubMed description and removed Revision: v3.2.0.SummaryDifference0.0%

- Check17 days agoChange DetectedThe government funding status notice was removed from the page. Core study details, contacts, and locations are unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedThe observed changes consist mainly of formatting adjustments and minor content updates on the study page, with no alterations to core details such as eligibility criteria, primary outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded a new reference to a study on avacopan for ANCA-associated vasculitis (ADVOCATE Study Group) with full citation and DOI.SummaryDifference0.8%

- Check60 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.SummaryDifference2%

- Check68 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to content.SummaryDifference0.0%

Stay in the know with updates to ADVOCATE: Avacopan Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVOCATE: Avacopan Clinical Trial page.